Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-07-17
1988-08-09
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514292, 514267, 546 83, 546 82, 544250, A61K 31345, C07D49804, C07D51304
Patent
active
047628430
ABSTRACT:
Hetero [f] fused carbocyclic pyridines are described, as well as methods for the preparation and pharmaceutical compositions of same, which are useful as dopamine agonists with selectivity for the presynaptic dopamine receptor and are useful as dopaminergic, antipsychotic and antihypertensive agents as well as for treating hyperprolactinaemia-related conditions and central nervous system disorders.
REFERENCES:
patent: 4198415 (1980-04-01), Kornfeld et al.
patent: 4501890 (1985-02-01), Nichols et al.
patent: 4537893 (1985-08-01), Titus et al.
patent: 4552956 (1985-11-01), Booher et al.
patent: 4596871 (1986-06-01), Schaus et al.
Caprathe Bradley W.
Jaen Juan C.
Wise Lawrence D.
Daignault Ronald A.
Lee Mary C.
Richter J.
Warner-Lambert & Company
LandOfFree
Hetero [f] fused carbocyclic pyridines as dopaminergic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hetero [f] fused carbocyclic pyridines as dopaminergic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hetero [f] fused carbocyclic pyridines as dopaminergic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-918823